C.T. Fitzpatrick Vulcan Value Partners
C.T. Fitzpatrick is the founder of Vulcan Value Partners, a firm that seeks high-quality businesses when they trade at discounts to estimated intrinsic value. Vulcan is known for a disciplined appraisal process and a willingness to hold cash when bargains are scarce. The firm’s equities strategies are widely followed in quality-value circles.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryan Specialty Holdings
RYAN
|
+$219M |
| 2 |
TransUnion
TRU
|
+$87.3M |
| 3 |
Ares Management
ARES
|
+$54M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$53.1M |
| 5 |
CoStar Group
CSGP
|
+$46.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medpace
MEDP
|
+$86.8M |
| 2 |
IQVIA
IQV
|
+$77.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$48.3M |
| 4 |
UnitedHealth
UNH
|
+$39M |
| 5 |
SS&C Technologies
SSNC
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.58% |
| 2 | Technology | 24.5% |
| 3 | Healthcare | 10.69% |
| 4 | Consumer Discretionary | 10.67% |
| 5 | Industrials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Genpact
G
$6.24B
| $34.9M | 0.63% |
746,570
-3,654
| -0.5% | -$158K |
|
27
ABM Industries
ABM
$2.74B
| $27.9M | 0.5% |
658,777
-5,277
| -0.8% | -$232K |
|
28
Colliers International
CIGI
$5.47B
| $27.1M | 0.49% |
184,403
-1,665
| -0.9% | -$250K |
|
|
29
Medpace
MEDP
$17.3B
| $26.6M | 0.48% |
47,306
-152,866
| -76% | -$86.8M |
|
30
MillerKnoll
MLKN
$1.57B
| $25.7M | 0.46% |
1,389,715
+272,783
| +24% | +$4.45M |
|
31
Ituran Location and Control
ITRN
$1.01B
| $23.4M | 0.42% |
540,059
-62,305
| -10% | -$2.44M |
|
32
Fortune Brands Innovations
FBIN
$5.32B
| $17.7M | 0.32% |
353,520
+54,492
| +18% | +$2.74M |
|
33
PROG Holdings
PRG
$1.54B
| $17.7M | 0.32% |
599,125
-3,746
| -0.6% | -$112K |
|
|
SARO
34
StandardAero Inc
SARO
$8.29B
| $13.6M | 0.25% |
+473,415
| New | +$12.9M |
|
35
Park Hotels & Resorts
PK
$3.18B
| $13.5M | 0.24% |
1,257,968
+678
| +0.1% | +$7.26K |
|
36
Virtus Investment Partners
VRTS
$1.12B
| $12.6M | 0.23% |
77,326
-1,941
| -2% | -$328K |
|
37
Timken Company
TKR
$8.67B
| $11.6M | 0.21% |
138,434
-110,166
| -44% | -$8.76M |
|
38
Middleby
MIDD
$5.22B
| $10.4M | 0.19% |
69,825
-799
| -1% | -$105K |
|
|
SEE
39
DELISTED
Sealed Air
SEE
| $4.91M | 0.09% |
118,417
-343,503
| -74% | -$13.3M |
|
40
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $4.14M | 0.07% |
6,023
+5,720
| +1,888% | +$3.87M |
|
41
iShares Russell 1000 Value ETF
IWD
$84.2B
| $636K | 0.01% |
+2,748
| New | +$568K |
|
|
42
SS&C Technologies
SSNC
$19.5B
| – | – |
-394,720
| Closed | -$35M |
|
43
Skyworks Solutions
SWKS
$10.1B
| – | – |
-311,645
| Closed | -$24M |
|
Similar funds
C.T. Fitzpatrick's Q4 2025 Portfolio in Review
As of Q4 2025, C.T. Fitzpatrick held 43 positions worth $5.54B, up 0.48% from $5.52B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
C.T. Fitzpatrick's Q4 2025 filing shows 3 new, 11 increased, 27 reduced and 2 closed positions. Its largest new stake was TransUnion: 1,062,584 shares worth $91M. The largest sale was Medpace, an estimated $86.8M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
- C.T. Fitzpatrick's largest Q4 2025 buy was TransUnion: 1,062,584 shares worth $91M.
- C.T. Fitzpatrick added most to Ryan Specialty Holdings in Q4 2025, an estimated $219M increase.
- C.T. Fitzpatrick's biggest Q4 2025 reduction was Medpace, cutting an estimated $86.8M.
- C.T. Fitzpatrick fully exited SS&C Technologies in Q4 2025, selling an estimated $35M.
- C.T. Fitzpatrick's ten largest holdings make up 66% of its $5.54B portfolio in Q4 2025.
- C.T. Fitzpatrick opened 3 new positions and closed 2 in Q4 2025.
- C.T. Fitzpatrick's portfolio value rose 0.48% quarter-over-quarter to $5.54B.
Based on Vulcan Value Partners's 13F filing for Q4 2025, filed 9 Feb 2026.